Clinical trials
Expanded access Lambert-Eaton Myasthenic Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 4 |
| Approved for marketing | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Catalyst Pharmaceuticals, Inc. | 1 |
| David P. Richman, MD | 1 |
| Lahey Clinic | 1 |
| Louis H. Weimer, MD | 1 |
| Oregon Health and Science University | 1 |
| The Cleveland Clinic | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lambert-Eaton Myasthenic Syndrome | 7 |
| Myasthenic Syndromes, Congenital | 3 |
| Nystagmus, Pathologic | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.